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Abstract
Background: Previously, gene normalization (GN) systems are mostly focused on disambiguation using contextual
information. An effective gene mention tagger is deemed unnecessary because the subsequent steps will filter out
false positives and high recall is sufficient. However, unlike similar tasks in the past BioCreative challenges, the
BioCreative III GN task is particularly challenging because it is not species-specific. Required to process full-length
articles, an ineffective gene mention tagger may produce a huge number of ambiguous false positives that
overwhelm subsequent filtering steps while still missing many true positives.
Results: We present our GN system participated in the BioCreative III GN task. Our system applies a typical 2-stage
approach to GN but features a soft tagging gene mention tagger that generates a set of overlapping gene mention
variants with a nearly perfect recall. The overlapping gene mention variants increase the chance of precise match
in the dictionary and alleviate the need of disambiguation. Our GN system achieved a precision of 0.9 (F-score
0.63) on the BioCreative III GN test corpus with the silver annotation of 507 articles. Its TAP-k scores are competitive
to the best results among all participants.
Conclusions: We show that despite the lack of clever disambiguation in our gene normalization system, effective
soft tagging of gene mention variants can indeed contribute to performance in cross-species and full-text gene
normalization.
Background
An essential step in biological text mining, gene normal-
ization (GN) is to link a mention of gene or gene pro-
duct appearing in a text to a standard database identifier
referring to a specific gene entity [1,2]. Gene normaliza-
tion is uniquely challenging for many reasons. First,
genes are an evolving concept in biology and gene
names are created and eliminated constantly. As a
result, there are many nomenclature standards but
authors rarely follow the standards strictly. Meanwhile,
orthologous genes and gene products of different species
may share the same names but have different database
identifiers and create ambiguity [3].
Many GN systems have been developed since the Bio-
Creative (BC) 1B task challenge evaluation [4]. The task
is to normalize genes of three selected model organisms.
The results suggest that GN performance may be organ-
ism-dependent due to the naming conventions asso-
ciated with each organism [4]. The subsequent
BioCreative II GN task focused only on human genes.
The best team achieved a F-score of 0.81 [5], which is
comparable to that of the BC 1B. A typical GN system
usually consists of gene mention tagger, dictionary,
matcher and disambiguation modules, a two-stage
approach where the first stage is to use a tagger to tag
all gene mentions in a text followed by the second stage
of matching gene mentions to a dictionary and then
resolving disambiguation, if multiple entries are matched
[6]. Lau et al. [7] used a rule-based system and achieved
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an F-score of 0.86, also with a rule-based system. GENO
[9] used both symbolic and statistical methods to
achieve a F-score of 0.86 (precision: 0.878, recall: 0.850).
All of the above results and many other related GN sys-
tems were evaluated on the BioCreative II GN dataset
and applied a relatively simple or out-of-shelf gene men-
tion tagger, and emphasized more on dictionary match-
ing and disambiguation. Baumgartner et al. [10] and
Vespoor et al. [11] therefore suggested that with clever
dictionary matching and disambiguation, performance of
a GN system is largely dependent on the recall but not
the precision of the underlying gene mention tagger
because false positive gene mentions will be filtered out.
Since it is straightforward to have high recall if precision
can suffer, this conclusion seems to implicitly imply that
improvement in gene mention tagging is unnecessary
for high performance GN systems. This point of view
was further corroborated by the fact that some of the
top performing gene mention taggers in the BioCreative
II gene mention (GM) task failed to deliver good results
in the BC II GN task, though this is partly because the
training corpus of the BC II GM is incompatible with
the BC II GN task. The GM corpus contains genes and
gene products of all species as well as mentions of gene
family that have no database IDs at all, while the BC II
GN task focused only on human genes.
Unlike similar tasks in the past BioCreative challenges,
the GN task of BioCreative III is particularly challenging
because it is not species-specific. Moreover, instead of
using abstracts, it is required to process full-length arti-
cles. These differences make the task closer to the real
literature curation tasks by human curators but in such
a setting, an ineffective gene mention tagger may pro-
duce a huge number of ambiguous false positives that
overwhelm subsequent filtering steps while still missing
many true positives of GN.
In this paper, we show that improvements in gene
mention tagging can indeed contribute to performance
in cross-species and full-text GN. We present our GN
system participated in the BioCreative III GN task [12].
The gene mention tagger in our GN system is an
advanced version of AIIAGMT (version 2.0.1) [13-15],
which was first developed for the BioCreative II gene
mention tagging (GM) task [16]. In 2007, we built a
Conditional Random Fields (CRF)-based gene mention
tagging system [17] by integrating bi-directional parsing
with a rich set of features. It achieved a F-score of
0.8683 (with a precision of 0.8930 and a recall of
0.8449) on the BC II GM test corpus and ranked the
second among 21 participants [17]. In order to maxi-
mize the potential of integrated bi-directional parsing
models, we attempted different asymmetric feature set-
tings to establish up to 6 models and integrated them
according to the CRF output scores. The integrated
model achieved 0.8830 in F-score (with precision 0.8895
and recall 0.8765), a significant improvement from the
original version. This work was incorporated into the
BioCreative MetaServer [15] and distributed indepen-
dently as AIIAGMT [14] since.
We extended AIIAGMT further for the GN task. The
latest version features soft tagging, in the sense that our
tagger tags sets of overlapping gene mention variants with
accurately estimated confidence scores. Soft tagging allows
for a higher chance of precise match in the gene name dic-
tionary. The recall of soft tagging is nearly perfect (0.9826
on the BioCreative II corpus) and therefore, it is highly
likely that one of the overlapping variants is a correct gene
mention. Soft tagging uses an ensemble of taggers for GN
as in [10,14] but is fundamentally different in that soft tag-
ging makes no attempt to select the best pair of bound-
aries for overlapping gene mention candidates but retains
all high confident candidates for dictionary matching. Soft
tagging effectively provides soft boundaries of a gene men-
tion. As a result, the need to deal with spelling variations,
partial matches and ambiguities can be alleviated.
Other key features of our GN system include:
￿ Short form-long form filtering: We have developed
an accurate abbreviation definition detector BIOADI
[18] and we used it to filter out incorrectly tagged gene
mentions.
￿ Species resolution before dictionary matching: Since
ambiguous gene names are rare within a single species
[19], our system resolved species first and therefore
minimized the need of disambiguation.
￿ Regular expression extension of Entrez Gene records
retrieved by a document retrieval system: We applied a
document retrieval system for dictionary matching. We
have an idea of a data-driven approach to dictionary
matching so that the problem of GN can be solved as
information retrieval, but at this moment, we have not col-
lected a sufficiently large corpus of documents to serve as
the dictionary. Instead, we used regular expression to
expand entries in Entrez Gene records and then used reg-
ular expression again to filter out false query results.
Our GN system achieved a precision of 0.64 and a
recall of 0.59 (F-score of 0.614) on the BioCreative III
GN training corpus and a precision of 0.90 and a recall
of 0.49 (F-score of 0.633) on the BioCreative III GN test
corpus with the silver annotation of 507 articles. Its
TAP-k scores are competitive to the best results among
all participants, never ranked below third in all combi-
nations of test corpora and the selection of k.
Methods
Data preprocessing
The training and test data of the BioCreative III GN
task, provided by the BioCreative organizers, consist of
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(PMC) XML files and PDF files. We parsed the PMC
XML files to plain-text files by XPath. Then we
extracted sections without a sec-type attribute to
exclude References, Methods, Materials, etc. and seg-
mented each remaining section into sentences as our
input data for gene normalization. We did not use PDF
files.
System organization
Figure 1 illustrates the system organization of our GN
system, which consists of four modules:
￿ gene mention tagging module (GMT) tags variants
of overlapping gene or gene product mentions from the
input text. These variants are candidate mentions that
may overlap with other candidate mentions but have
different boundaries.
￿ gene mention evaluation module (GME) evaluates
the quality of gene mentions extracted by the GMT by
estimating their confidence scores.
￿ species designation module (SD) designates a species
(more specifically, taxonomy id) to each variant.
￿ gene normalization module (GNM) assigns a corre-
sponding Entrez Gene record ID to each variant.
GMT and GME together accomplish the soft tagging
of overlapping high confidence gene and gene product
mention variants in our gene normalization system. The
system was implemented in Java 1.6.0 running on 32-bit
Linux. Implementation of model learning and inference
algorithms that we used, including CRF and logistic
regression, was modified from the source codes of
MALLET 2.0 [20].
Soft tagging: gene mention tagging module
Our gene mention tagger was modified from AIIAGMT
that we developed [14]. One of the changes is that we
reduced the number of features from ~5 million to ~2
million to improve the computational performance with-
out sacrificing accuracy. The feature types removed were
Part-of-Speech (POS) tags and sliding window features
of POS-tags and case-sensitive words.
We then attempted to maximize the recall of our gene
mention tagger as suggested in [6,10], yet maintain the
false positives at a manageable level. We used a finding
in our previous work that the union of the top most-
probable tagging solutions by bi-directional parsing
models may achieve a nearly perfect recall [14].
For example, given a sentence as follows:
Acetyl-CoA carboxylase from yeast is an essential
enzyme and is regulated by factors that control phos-
pholipid metabolism.
In this case, “Acetyl-CoA carboxylase” is the only gene
mention tagging acceptable by bio-curators. Figure 2
shows some of the tagging solutions by a CRF model
for this example. The sentence will first be converted
into a list of tokens using fine-grained tokenization by
breaking any non-alphabet/digit characters. Then a CRF
model will label each token using IBO2 representation.
Usually, only the most probable labeling will be selected
as the solution. But to maximize recall, we let each
model generate the top 20 most probable solutions. Fig-
ure 2 shows seven of them. These solutions were
inferred by the Viterbi “Max-(Product)-Lattice” algo-
rithm implemented in Mallet [20] based on the given
CRF model parameters. Since we have forward parsing
and backward parsing models, combining their solutions
gives 40 solutions for each sentence. We computed
union of these solutions for the BC II GM corpus and
evaluated the result, which showed that recall of such a
tagger was 0.9826 with a precision of 0.1902. That is,
this result comprises of nearly all true-positives of the
corpus.
These solutions tend to overlap and differ in their
boundaries. Decoding the IBO2 representation into
Figure 1 GN System Organization
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2, we obtain five non-redundant gene mentions:
￿“ Acetyl-CoA carboxylase”,
￿“ CoA carboxylase”,
￿“ essential enzyme”,
￿“ carboxylase”,
￿“ CoA carboxylase from yeast”
These gene mentions can be regarded as variants of
the true positive “Acetyl-CoA carboxylase.” As
described above, we expected that one of the variants
could be a true-positive. But instead of committing to
as i n g l ehard choice of the boundaries, we make soft
choices by tagging a set of overlapping variants with
different boundaries. With these variants, we can avoid
putting efforts into manually creating rules to remove
descriptive words preceding or following a gene men-
tion to match gene names in Entrez Gene database,
such as {human, rat, mouse, gene, protein, mRNA,
cDNA, oncogene}.
However, these variants will overwhelm the GN per-
formance by abundant false positives. There is a need to
evaluate the quality of mentions to set priority among
variants. Thus, we developed the GME module to esti-
mate a confidence score of each variant. It helps us to
remove most false positives without harming the high
recall from combined solutions. Tagging overlapping
gene and gene product mentions with confidence scores
is what we refer to as soft tagging. The details of confi-
dence score estimation will be described in next section.
We also used BIOADI [18] to filter out false positives.
BIOADI can automatically identify all pairs of abbrevia-
tion and its long form definition in an article. If a long
form is not tagged in the sentence but its abbreviation
is tagged, all appearances of that abbreviation in the
article will be marked as invalid and will be eliminated
from the result of the GMT module.
For example, “NAA” is a potential gene variant tagged
in the following text:
Figure 2 Soft Tagging of Gene Mention Variants
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creatine…
“NAA” is identified by BIOADI as the abbreviation
of “N-acetyl-aspartate.” Suppose that a gene mention
tagger mistakenly identifies “NAA” as a gene mention.
However, from the linkage of “NAA” and “N-acetyl-
aspartate,” we can infer that NAA may not a valid
gene mention. Therefore, all “NAA” tagged in the sen-
tences of the same article will be considered false posi-
tives and eliminated from the output. Table 1 shows
the impact of the application of BIOADI to the GN
task, evaluated on the training corpus of the BC III
GN task. The result shows that it mainly contributed
to the precision.
Soft tagging: gene mention evaluation module
The GME module assigns a confidence score to each of
the variants tagged softly by the GMT module in the
corpus to complete the soft tagging process. We did not
use scores from the CRF model as our previous work
[14] for this purpose because CRF scores are for the
labeling of a whole sentence, where there could be mul-
tiple gene mentions. But here we want scores for var-
iants of gene mentions. Ideally, these scores of variants
of overlapping gene mentions should reflect the prob-
ability that a variant is a true positive.
Training data preparation
We used a machine learning method to evaluate and
score each variant extracted by the GMT module. The
training data was extracted from the BC II GM training
corpus (15,000 sentences) where 10,000 sentences were
used to train a new CRF model and the remaining 5,000
sentences for testing. The CRF models tagged 90,398
unique instances (variants) which were annotated as
either bio-curator approved gene mention or not. The
annotation is available from the BioCreative II GM
training corpus, which includes manually identified gene
mentions and acceptable alternatives (variants) by bio-
curators. For instance, {“amniotic fluid alpha fetopro-
tein”, “fluid alpha fetoprotein”, “alpha fetoprotein”,
“alpha” } are four variants of “amniotic fluid alpha feto-
protein”,b u to n l y“amniotic fluid alpha fetoprotein” and
“alpha fetoprotein” are bio-curator acceptable variants.
These variants are annotated as positive examples while
others are negatives. We therefore created a new corpus
of 23,533 positive and 66,865 negative examples to train
machine learning models.
Feature design
We designed a set of features characterizing the distinc-
tion between positive and negative examples and divided
them into four types as follows:
￿ Frequency of Variant: The frequency is a measure of
how frequent a variant occurs in the set of combined 40
solutions. For example, consider the set of solutions
shown in Figure 2. “Acetyl-CoA carboxylase” is tagged
three times, “CoA Carboxylase” and “essential enzyme”
twice, and all others once. These counts are then nor-
malized as their frequncy. Figure 3 demonstrated posi-
tive correlation between frequency and precision when
tested on the BC II GM training corpus, suggesting that
a variant with a high frequency is more likely to be a
true positive.
￿ Morphological Features: This type of features
describes variants’ morphology to differentiate between
common words and gene mentions listed as:
– Has uppercase/lowercase/digit
– Start with uppercase/lowercase/digit
– End with uppercase/lowercase/digit
For example, “IL2R” is an abbreviation of “interleukin
2 receptor.” It starts with an uppercase “I” and ends
with an uppercase “R.” Starting and ending with upper-
case letters is rare among common English words.
￿ Content Features: Content tokens are tokens of gene
variants. For example, “alkaline” and “phosphatases” are
the content tokens of “alkaline phosphatases.” The con-
tent tokens of a variant is the most informative to reveal
its identity. For example, the word “gene” is one of the
tokens in “beta-galactosidase reporter gene”.T h et o k e n
“gene” is a good indicator that “beta-galactosidase repor-
ter gene” is highly likely to be a gene mention. Before
extracting this type of features, we normalized each var-
iant to lowercase letters and removed all punctuations,
then tokenized it into a list of tokens.
￿ Contextual Features: The contextual background is
also valuable. We defined two tokens preceding and fol-
lowing gene variants as context tokens. For example, the
contextual background of “cat” from a passage “…with
the cat gene of the S. aureus…”clearly shows that “cat”
is a gene rather than an animal.
From 90,398 training examples, we extracted 385,678
features. Most of them are binary features. Only the fre-
quency of variant is continuous ranging from 0 to 1.
Model training and evaluation
We chose the logistic regression model for gene men-
tion evaluation to take advantage of its continuous out-
put between 0 and 1. We regarded the output value as a
confidence score to indicate the importance of each var-
iant. By using the features described above, we evaluate
the performance of the model by 5-fold cross-validation
on the training examples. It achieved an average accu-
racy of 0.9220 with a standard deviation of 0.0207.
Table 1 GN Performance with or without BIOADI on the
BioCreative III GN training corpus
Setting Precision Recall F-score TAP-5 TAP-10 TAP-20
Without BIOADI 0.6248 0.5961 0.6101 0.3252 0.4117 0.4117
With BIOADI 0.6316 0.5911 0.6107 0.3092 0.4190 0.4190
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and regarded it as a scoring function for each variant.
To evaluate its efficacy, we tested it on the BioCreative
II GM test corpus. By setting different score cutoff
thresholds, we can measure the changes of performance
related to the thresholds. When tested on the GM test
corpus, we designed a recursive algorithm to select
exactly one with the maximal score from overlapping
variants. Figure 4 shows the performance with different
thresholds. The result shows that the precision keeps
growing as the threshold increases, while the recall
declines. The number of false positives drops from 1210
with no threshold to 627 with threshold = 0.5.
The score helps determining the boundaries of var-
iants, which is crucial to dictionary matching. For exam-
ple, there are two variants of gene mentions in “human
Na,K-ATPase beta subunit,” with their scores: {“human
Na,K-ATPase beta”, 0.9957} and {“human Na,K-
ATPase”, 0.9316}. Without “beta,” it would be impossi-
ble to retrieve the correct gene ID.
In our GN system, we did not select the best variants
but only use the threshold for filtering. For the BC 3
GN task, we used 0.2 as the threshold.
Species designation module
One of the major causes of gene name ambiguity is
sharing of gene names of different species. Otherwise,
ambiguous names are rare for genes of a single spe-
cies. The ambiguity mostly comes from homology,
gene family, and overlaps and evolving of nomencla-
ture standards. Chen et al. [19] reported a study show-
ing that only 0.02% official symbols were ambiguous
within the organisms but for 21 organisms combined,
14.2% of symbols were ambiguous. The dictionary
provided for the BC II GN task contains a large col-
lection of unofficial synonyms of gene names for
human. Among 177,200 distinct names for 32,975
gene entities, only 4,267, or 2.408%, are ambiguous,
confirming that even if unofficial aliases are consid-
ered, ambiguous names are relatively rare for human
genes. Consequently, a better strategy of GN is to des-
ignate species before assigning a gene ID for a candi-
date gene mention.
The species designation module is to designate each
variant a NCBI taxonomy database [21] standard iden-
tifier (TaxID). We built a module based on dictionary
matching and three heuristic designation rules to
achieve the goal. By merging dictionaries of the NCBI
taxonomy database and LINNAEUS [22], which con-
tains dictionary packs for cell lines-species and gen-
era-species reference, we established a dictionary of
5,770 entries of species names (included in Entrez
Gene records). Each entry is linked to a specific
TaxID. In this dictionary, each TaxID has a median of
Figure 3 Frequency versus GM Performance
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(human).
To assign species to variants, we used three rules as
described in [23]. The first rule (Rule 1) is to assign
TaxID of the species mentioned within or preceding the
variant (including prefix characters, such as {h, y, m, r,
d }i n d i c a t e{ h u m a n ,y e a s t ,m o u s e ,r a t ,f r u i tf l y } ,r e s p e c -
tively). The second rule (Rule 2) is to assign TaxID
located in the same sentence. Lastly, the third rule (Rule
3) is to assign TaxID of the species mentioned most
often in the entire article. With Rule 3, we can assure
that all variants will be assigned with one TaxID.
Gene normalization module
T h eG Nm o d u l et h a tw eb u i l ti st oa s s i g nas e to fo v e r -
lapping gene mention variants to a specific identifier
(GeneID) of Entrez Gene records [24]. Previous works in
GN emphasized heavily on disambiguation of multiple
matches of a gene mention against a dictionary. However,
previous works mostly tried to solve single-species GN
from abstracts, while gene name ambiguity in a single
species is rare. Then where did all the ambiguous
m a t c h e sc o m ef r o m ?O u ra n s w e ri st h a tt h i si sb e c a u s e
the coverage of dictionaries is not sufficient to cover all
gene name aliases and their spelling variants. To deal
with this, many GN systems used approximate string
matching and created many “artificial ambiguities.”
One of our solutions to deal with this problem is to
retain all overlapping variants with confidence scores
higher than a threshold by soft tagging. The idea is to
increase the chance to find a match in the dictionary.
Our solutions also include to designate species first and
to construct a high coverage dictionary. However, due
to time and resource constraints, it was prohibitive for
us to construct a high coverage dictionary before the
submission deadline. Instead, we extended the indexing
and retrieval functions of a document retrieval system
for dictionary matching as our current solution. The
resulting module is composed of two phases: retrieval
phase and resolving phase.
Retrieval phase
We designed the retrieval phase to speed up the retrieval
of the most relevant gene entries and to narrow down
the search space to a small fraction of gene entries to
reduce the expensive computation in the resolving phase.
W eu s e dA p a c h eL u c e n e[ 2 5 ] ,ah i g h - p e r f o r m a n c ea n d
full-featured text search engine library, to index the
entire Entrez Gene entries and to retrieve the corre-
sponding gene entries of gene mention variants.
We obtained gene names from the columns of {Sym-
bol, Synonyms, dbXrefs, description, Symbol from
nomenclature authority, Full name from nomenclature
authority, Other designations} of gene_info.gz [26]. We
created an index for each gene name with its sources
Figure 4 Cutoff Threshold versus GM Performance
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Lucene. A gene name will be listed with its sources as in
this example:
(“TaxID:9606”, “GeneID:3552”, “IL1-ALPHA”,
“Synonyms”).
Before tokenization performed by Lucene for indexing,
we passed the text of the name through a preprocessing
step of five rules given in Table 2 to cover more spelling
variants and changed all uppercase letters into lowercase
letters to ignore case sensitivity. Besides, {1, 2, 3, …} and
{I, II, III, …}, as well as {alpha, beta, gamma, …}a n d{ a ,
b, g, …}, were regarded as interchangeable. Compiling a
query consists of two steps:
1. We transform gene variants with the rules given in
Table 2 to obtain a normalized (extended text) for gene
name search. In this example, the gene name “IL1-
ALPHA” will be transformed into the follows: i1⌴(?i:1|i)⌴
(?i:a|alpha)
2. We use the taxonomy id obtained from the species
designation module as the second criterion for TaxID
search. In this case, the TaxID will be 9606 (Homo
sapiens).
To retrieve the most relevant entries against a given
set of variants, we compiled a query with each variant
text and its TaxID to search the indexed entries in
Lucene. We regarded the top 50 search results returned
by Lucene as the candidates. For example, the search
results listed in Table 3 are Lucene’ss e a r c hr e s u l t sw i t h
regard to the query (TaxID:9606, “IL-1 alpha”). Then a
regular expression pattern derived from the query text
were used to filter out the results whose names failed to
match the pattern before the search results were passed
to the next phase. This process is necessary to remove
partial matches returned by Lucene. In this case, the
query text is “IL-1 alpha” and the query results are
given in Table 3. The entries with the gene names of
{IL1A, IL1ALPHA, IL-1A, IL-1 alpha} will be retained
because they match the regular expression pattern of
“IL-1 alpha”.
Since the GME module retains all overlapping variants
unless their confidence scores are below the threshold,
for a set of overlapping variants at most a Entrez Gene
ID should be returned in the final output. Usually
different variants will match the same Entrez Gene ID.
But still in some cases, they may match different Entrez
Gene IDs. For example, “IL-1 alpha” and “IL-1” are two
overlapping variants that match two distinct Entrez
Gene IDs. To determine a correct Entrez Gene ID, our
approach is to choose the match of the longest variant.
This is a simple yet reasonable approach to
disambiguation.
Resolving phase
The retrieval phase produces a list of entries as shown
in Table 4. If there is only one unique GeneID in the
list, we assigned the GeneID to the given variant. In this
example, “IL-1 alpha” will be assigned to GeneID:3552.
If more than one unique GeneID in the list, we used a
heuristic approach to GeneID assignment: assign the
GeneID of an entry which was extracted from the col-
umns {Symbol, Symbol from nomenclature authority,
full name from nomenclature authority} in Entrez Gene
Records. If none satisfies this prerequisite, we will ignore
this list of entries. We used the score of each variant
Table 2 Rules for Tokenization before Lucene Indexing
Rule Regular Expression Replacement
1 ([A-Z]{2,})([a-z]{2,}) $1⌴$2
2 ([a-z]{2,})([A-Z]{2,}) $1⌴$2
3 [\w\_&&[^\.]] ⌴
4 ([\d\.]+) ⌴$1⌴
5 \s+ ⌴
⌴ is used to represent a character space.
Table 3 Example of Top 20 Names Retrieved by Lucene
in the GN Retrieval Phase
TaxID GeneID Name Column Header Lucene
Score
9606 3552 ILIA Synonyms 1.0000
9606 3552 IL1ALPHA Synonyms 1.0000
9606 3552 IL-1A Synonyms 1.0000
9606 3552 IL1A AuthorizedSymbol 1.0000
9606 3552 IL1-ALPHA Synonyms 1.0000
9606 3552 IL1A Symbol 1.0000
9606 3552 IL-1 alpha OtherDesignations 1.0000
9606 3554 IL-1R-alpha Synonyms 1.0000
9606 26525 IL1F5 (Canonical
product IL-1F5a)
OtherDesignations 0.7459
9606 27177 IL1F8 (Canonical
product IL-1F8a)
OtherDesignations 0.7459
9606 84639 IL-1F10 (canonical form
IL-1F10a)
OtherDesignations 0.7459
9606 3552 IL1 Synonyms 0.6417
9606 3553 IL1 Synonyms 0.6417
9606 3553 IL-1 Synonyms 0.6417
Table 4 Example of Matched Names in the GN Resolving
Phase
TaxID GeneID Name Column Header Lucene Score
9606 3552 IL1A Synonyms 1.0000
9606 3552 IL1ALPHA Synonyms 1.0000
9606 3552 IL-1A Synonyms 1.0000
9606 3552 IL1A AuthorizedSymbol 1.0000
9606 3552 IL1-ALPHA Synonyms 1.0000
9606 3552 IL1A Symbol 1.0000
9606 3552 IL-1 alpha OtherDesignations 1.0000
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final score as the GN output.
Results and discussion
Performance of soft tagging
Soft tagging is accomplished by the gene mention tag-
ging module and gene mention evaluation module in
our gene normalization system. Advantages of soft tag-
ging include: First, we can use the confidence scores to
adjust the trade-off between recall and precision by set-
ting a cutoff threshold to remove variants below a
threshold. Second, the scores of variants are useful to
set priority when we are required to make a choice
among them. To analyze the performance of soft tagging
as a gene mention tagger, we tested it on the BioCrea-
tive II test corpus. Each variant has a confidence score
estimated by the GME module. At first, we did not do
any selection of these variants by their scores. We then
tested its gene mention tagging performance with differ-
ent thresholds. The results are shown in Figure 5. The
results show trade-off between precision and recall.
When the threshold is set to 0.2, the recall is 0.9281
and precision is 0.7168, a 6 percent drop in recall from
zero threshold but a 50 percent gain in precision. Com-
pared to our previous work [17], the new GM module
with the best F-score 0.8576 performs one percent
lower than the best GM F-score of our submission to
the BC II GM task, which achieved 0.8683 F-score with
a precision of 0.8930 and a recall of 0.8449. This is
mostly because overlapping tagging solutions contain
o n l ya tm o s to n et r u ep o s i t i v eb u tt h eo t h e r sa r ea l l
false positives. The precision will therefore suffer much
because of these false positives. To alleviate this type of
error, we designed a recursive algorithm to select var-
iants with the highest score within a passage of a text.
Thus only variants with the highest score will be tagged
as the GM results. The performance with this selection
is reported in Figure 5. The F-score was improved to
0.8807 with a precision of 0.8972 and a recall of 0.8648
with 0.5 threshold. This is 1.2 percent higher than our
previous work. Compared to its “without-selection”
counterpart, it accomplished nearly 3 percent of
improvement in F-score from 0.8522 to 0.8807. Conse-
quently, soft tagging with estimated confidence scores
can improve the performance of gene mention tagging.
Evaluation of species designation module
We used three heuristic rules to designate TaxID for
each variant. To analyze their impact on gene normali-
zation, we tested their combinations on the BioCreative
III Training corpus of 32 full-annotated articles, and
regarded Rule 1 as the baseline. The results are listing
in Table 5. The use of Rule 1 achieved a F-score of
0.3434, with the highest precision of 0.7432 among all
tests. Recall that Rule 1 is the most intuitive rule to des-
ignate a species to a variant when a species preceding
the variant. Rule 1+2 achieved a 7 percent improvement
in the recall, but lost 5 percent in the precision, suggest-
ing that designating species co-located with variants in
the same sentence provides modest contribution when
Rule 1 is not applicable. Remarkably, Rule 1+2+3 boosts
the recall by about 20 percent compared to the perfor-
m a n c eo fR u l e1 + 2a n dR u l e3o n l yt u r n so u tt op e r -
form better than both Rule 1 and Rule 1+2. In fact, Rule
3 only even outperforms Rule 1+2+3 in TAP-5 even
though its F-score is worse. This may be due to the fact
that the number of output gene IDs using Rule 3 only is
larger than that using Rule 1+2+3 and TAP-k favors a
long list of output. Performance of Rule 3 shows that
analyzing text is required to designate species for a large
proportion of variants. A reasonable explanation is that
papers usually focus on a small number of organisms (e.
g., model organisms in experiments for a study of a
human disease).
Analysis of gene normalization module
We submitted 3 runs for the BioCreative III GN task
evaluation. As we know, the Entrez Gene database is
frequently updated. Run 1 and Run 2 used two different
versions of Entrez Gene downloaded in May 2010 and
Figure 5 Cutoff Threshold versus Performance on the BioCreative II GM test corpus
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Page 9 of 12July 2010, respectively. Run 3 is the union of Run 1 and
Run 2. The most remarkable difference between the ver-
sions of May and July is that all records of TaxID:4932
(Saccharomyces cerevisiae) were moved to
TaxID:559292 (Saccharomyces cerevisiae S288c). This
change caused a conflict with our taxonomy dictionary,
an integration of LINNEAUS and NCBI taxonomy data-
base downloaded in May 2010. All variants with
TaxID:4932 cannot be correctly designated to Entrez
gene entries, and must be redirected to TaxID:559292
for the version downloaded in July 2010.
To let participants evaluate the performance of these
submitted runs, the BioCreative organizers released four
annotations of the BioCreative III GN test corpus with
TAP-k [27] evaluation scripts version 1.3. One of them
is annotated by professional bio-curators and the others
are annotated automatically by team submissions using
the EM algorithm [12]. Table 6 reports the performance
of our submitted runs on these annotations. We
observed that there is no significant performance differ-
ence in F-scores and TAP scores (k =5, 10 and 20)
between Run 1 and Run 2 on these annotations. Next,
we found that the scores for the silver annotations are
usually double of those for the gold annotation of 50
articles of the BioCreative III GN test corpus, selected
from a total of 507 articles. Our GN system accom-
plished high precisions for the silver annotations, sug-
gesting that our results were consistent with other
participants’ results.
In the BioCreative III GN test evaluation, our Run 3
w a sr a n k e dt h ef i r s tf o rt h e5 0a r t i c l e su s i n gt h es i l v e r
standard annotations in TAP (k=5) among 37 submitted
runs from 14 teams and never ranked lower than the
third for any combination of annotations and k settings.
We observed that the TAP-k scores are usually the
same in our system. We suspected that it is because our
system produced a short list of records for an article to
have less then k false positives to appear and caused the
TAP scores to freeze at the value of TAP-5. Table 7
shows the min, median and max lengths of the output
gene ID lists from our GN system and the min, median
and max number of false positives, as well as the per-
centage of the number of missed genes (false-negatives).
Compared to “Truth,” the standard annotations pro-
vided by the organizers, apparently our output lists are
short but our system produced remarkably few false
positives especially for silver standards.
Future work
O u rf u t u r ew o r ki st oi m p r o v et h eG Ns y s t e mi na
number of ways. First, our current system is unable to
extract GN records from figures [28] and tables. Sub-
stantial gene information may appear in captions of fig-
ures and tables. Missing gene mentions in figures and
tables contributed to the low recall of our GN system.
Second, it is still challenging to match Entrez Gene
records with tagged gene mentions without accurate
species designation. It is quite likely that improvement
in species designation will result in substantial gain in
performance. Finally, we plan to develop a trainable
model for the entire GN process so that the system will
improve its performance with more traininge x a m p l e s .
Important progress in biomedical literature mining may
be accomplished by the development of models that
learn progressively throughout the task [3,29], that will
create a positive feedback loop [30]. Currently, our gene
normalization module is not trainable. It is possible to
develop a machine learning method to filter results of
dictionary matching and to resolve disambiguation if
necessary [31].
Conclusions
The key feature of our GN system is that we applied a
novel soft tagging approach that produces sets of high
Table 5 GN Performance versus Species Designation
Rules
Rule(s) Precision Recall F-score TAP-5 TAP-10 TAP-20
1 0.7432 0.2233 0.3434 0.2983 0.2983 0.2983
1+2 0.6980 0.2923 0.4120 0.3353 0.3353 0.3353
3 0.6360 0.5107 0.5665 0.3795 0.3926 0.3926
1+2+3 0.6316 0.5911 0.6107 0.3092 0.4190 0.4190
Table 6 Performance of Submitted Runs on the
BioCreative III GN test corpus
Annotation Run Precision Recall F-
score
TAP-5 TAP-
10
TAP-
20
R1 0.4494 0.2316 0.3056 0.2137 0.2509 0.2509
test50.gold R2 0.4289 0.2352 0.3038 0.2086 0.2483 0.2483
R3 0.4237 0.2364 0.3034 0.2099 0.2495 0.2495
R1 0.8801 0.4136 0.5627 0.3820 0.3820 0.3820
test50.silver R2 0.8632 0.4316 0.5755 0.3855 0.3855 0.3855
R3 0.8570 0.4360 0.5780 0.3890 0.3890 0.3890
R1 0.8433 0.4327 0.5720 0.4540 0.4540 0.4540
test507.
silver1
R2 0.8272 0.4377 0.5724 0.4536 0.4536 0.4536
R3 0.8233 0.4427 0.5758 0.4577 0.4577 0.4577
R1 0.9185 0.4743 0.6256 0.4873 0.4873 0.4873
test507.
silver2
R2 0.9048 0.4818 0.6287 0.4871 0.4871 0.4871
R3 0.9009 0.4875 0.6326 0.4916 0.4916 0.4916
test50.gold: human annotation for the 50 articles
test50.silver: pooled team submissions for the same 50 articles using the EM
algorithm
test507.silver1: human annotation for the 50 articles + pooled team results for
the remaining 457 articles
test507.silver2: pooled team submissions for all the 507 articles by the EM
algorithm
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Page 10 of 12confidence overlapping gene mention variants to maxi-
m i z et h ec h a n c eo fp r e c i s em a t c hi nad i c t i o n a r yw h i c h
is similar to Baumgartner et al. [10] while minimizing
artificial ambiguities due to the use of approximate
string matching to compensate low coverage of diction-
aries. Disambiguation by considering contextual infor-
mation is still important to a practical GN system. The
lack of use of any contextual information in the disam-
biguation in our GN system is mostly due to time and
resource constraints to meet the submission deadline.
Despite the lack of clever disambiguation, we show that
soft gene mention tagging is sufficient to produce com-
petitive gene normalization results in a cross-species
and full-text setting. This evaluation suggests that large
improvement is required to make automatic gene nor-
malization practical. However, given this encouraging
result, we are confident that by combining soft tagging
with trainable species designation and context-based dis-
ambiguation, the resulting system will perform much
better to actually meet the needs of bio-curation.
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